APA (7th ed.) Citation

M, Z., N, K., X, Y., X, Z., Q, D., X, M., . . . W, Z. (2025). Author Correction: TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis in Behçet's disease. Nature communications, 16(1), 366. https://doi.org/10.1038/s41467-024-55702-z

Chicago Style (17th ed.) Citation

M, Zhang, et al. "Author Correction: TNF Inhibitors Target a Mevalonate Metabolite/TRPM2/calcium Signaling Axis in Neutrophils to Dampen Vasculitis in Behçet's Disease." Nature Communications 16, no. 1 (2025): 366. https://doi.org/10.1038/s41467-024-55702-z.

MLA (9th ed.) Citation

M, Zhang, et al. "Author Correction: TNF Inhibitors Target a Mevalonate Metabolite/TRPM2/calcium Signaling Axis in Neutrophils to Dampen Vasculitis in Behçet's Disease." Nature Communications, vol. 16, no. 1, 2025, p. 366, https://doi.org/10.1038/s41467-024-55702-z.